Universal DX is a startup based in Spain, 1 tracked investor.
Universal DX is a company headquartered in Spain. Brouky records 1 investor associated with the company.
Universal DX is a molecular diagnostics company developing non-invasive blood tests for early cancer detection. Their flagship product, Signal-C, is a liquid biopsy test for colorectal cancer screening.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.